Literature DB >> 6193025

Kinetic analyses of the microsomal biotransformation of the phosphorothioate insecticides chlorpyrifos and parathion.

L G Sultatos, S D Murphy.   

Abstract

Chlorpyrifos [0,0-diethyl-0-(3,5,6-trichloro-2-pyridyl) phosphorothioate] was metabolized to chlorpyrifos oxon [0,0-diethyl-0-(3,5,6-trichloro-2-pyridyl) phosphate] and to 3,5,6-trichloro-2-pyridinol by mouse hepatic microsomes. Formation of both chlorpyrifos oxon and 3,5,6-trichloro-2-pyridinol required NADPH, and was inhibited by carbon monoxide. Kinetic analyses using direct linear plots determined the appKm's for formation of chlorpyrifos oxon and 3,5,6-trichloro-2-pyridinol to be 20.9 +/- 3.3 microM and 16.1 +/- 3.4 microM respectively, while the appVmax's for the same reactions were 3.9 +/- 0.2 nmols/100 mg liver/min and 8.1 +/- 0.3 nmols/100 mg liver/min respectively. Incubation of parathion [0,0-diethyl-0-(4-nitrophenyl) phosphorothioate] with mouse hepatic microsomes produced paraoxon [0,0-diethyl-0-(4-nitrophenyl) phosphate] and p-nitrophenol. The appKm's for the formation of paraoxon and p-nitrophenol were 29.6 +/- 4.2 microM and 26.5 +/- 3.8 microM respectively, with appVmax's of 5.8 +/- 0.6 nmols/100 mg liver/min and 6.7 +/- 0.5 nmols/100 mg liver/min, respectively. Incubation of both parathion and chlorpyrifos at various concentrations with mouse hepatic microsomes resulted in inhibition of production of paraoxon, p-nitrophenol, chlorpyrifos oxon, and 3,5,6-trichloro-2-pyridinol, which was characteristic of mixed type inhibition. This complex kinetic behavior could arise as a result of competitive interactions of parathion and chlorpyrifos with multiple forms of microsomal cytochrome P-450.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6193025     DOI: 10.1016/s0272-0590(83)80167-5

Source DB:  PubMed          Journal:  Fundam Appl Toxicol        ISSN: 0272-0590


  6 in total

1.  Cytochrome P450-specific human PBPK/PD models for the organophosphorus pesticides: chlorpyrifos and parathion.

Authors:  Robert J Foxenberg; Corie A Ellison; James B Knaak; Changxing Ma; James R Olson
Journal:  Toxicology       Date:  2011-04-13       Impact factor: 4.221

2.  Determination of chlorpyrifos and its major breakdown products in technical formulations.

Authors:  W J Allender; J Keegan
Journal:  Bull Environ Contam Toxicol       Date:  1991-02       Impact factor: 2.151

3.  PON1 status does not influence cholinesterase activity in Egyptian agricultural workers exposed to chlorpyrifos.

Authors:  Corie A Ellison; Alice L Crane; Matthew R Bonner; James B Knaak; Richard W Browne; Pamela J Lein; James R Olson
Journal:  Toxicol Appl Pharmacol       Date:  2012-09-10       Impact factor: 4.219

4.  Pharmacokinetics and pharmacodynamics of chlorpyrifos in adult male Long-Evans rats following repeated subcutaneous exposure to chlorpyrifos.

Authors:  Corie A Ellison; Jordan Ned Smith; Pamela J Lein; James R Olson
Journal:  Toxicology       Date:  2011-06-17       Impact factor: 4.221

5.  Differential sensitivity of plasma carboxylesterase-null mice to parathion, chlorpyrifos and chlorpyrifos oxon, but not to diazinon, dichlorvos, diisopropylfluorophosphate, cresyl saligenin phosphate, cyclosarin thiocholine, tabun thiocholine, and carbofuran.

Authors:  Ellen G Duysen; John R Cashman; Lawrence M Schopfer; Florian Nachon; Patrick Masson; Oksana Lockridge
Journal:  Chem Biol Interact       Date:  2011-12-24       Impact factor: 5.192

6.  Comparative effects of parathion and chlorpyrifos on extracellular endocannabinoid levels in rat hippocampus: influence on cholinergic toxicity.

Authors:  Jing Liu; Loren Parsons; Carey Pope
Journal:  Toxicol Appl Pharmacol       Date:  2013-08-07       Impact factor: 4.219

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.